ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 37 filers reported holding ALIGOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,649,631 | -23.1% | 3,547,030 | 0.0% | 0.29% | +21.8% |
| Q2 2023 | $3,444,166 | +11.1% | 3,547,030 | 0.0% | 0.24% | +10.7% |
| Q1 2023 | $3,100,104 | +91619.1% | 3,547,030 | 0.0% | 0.22% | -44.7% |
| Q4 2022 | $3,380 | -99.9% | 3,547,030 | 0.0% | 0.39% | -9.7% |
| Q3 2022 | $3,902,000 | -9.1% | 3,547,030 | 0.0% | 0.43% | 0.0% |
| Q2 2022 | $4,292,000 | -43.7% | 3,547,030 | 0.0% | 0.43% | -17.9% |
| Q1 2022 | $7,626,000 | -81.9% | 3,547,030 | 0.0% | 0.52% | -79.3% |
| Q4 2021 | $42,103,000 | -23.5% | 3,547,030 | 0.0% | 2.54% | +2.8% |
| Q3 2021 | $55,014,000 | -23.9% | 3,547,030 | 0.0% | 2.47% | -21.1% |
| Q2 2021 | $72,306,000 | -10.4% | 3,547,030 | 0.0% | 3.13% | +10.4% |
| Q1 2021 | $80,659,000 | -17.8% | 3,547,030 | 0.0% | 2.84% | -35.2% |
| Q4 2020 | $98,075,000 | – | 3,547,030 | – | 4.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $2,028,013 | 4.23% |
| TANG CAPITAL MANAGEMENT LLC | 3,424,800 | $2,993,275 | 0.45% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $649,570 | 0.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $552,269 | 0.23% |
| Vivo Capital, LLC | 3,547,030 | $3,100,104 | 0.22% |
| Newtyn Management, LLC | 1,021,461 | $892,757 | 0.18% |
| Logos Global Management LP | 1,000,000 | $874,000 | 0.12% |
| EcoR1 Capital, LLC | 3,948,360 | $3,450,867 | 0.11% |
| HHLR ADVISORS, LTD. | 2,309,764 | $2,018,734 | 0.04% |
| Baker Brothers Advisors | 2,076,400 | $1,814,774 | 0.01% |